Regarding the hotly anticipated Hong Kong IPOs, Goldman Sachs has prepared a Q&A highlighting key points.

Goldman Sachs stated that the robust rebound of the Hong Kong stock market, the relaxation of listing rules, and positive signals from regulators have collectively driven the recovery of IPOs in Hong Kong. It is expected that with the continued activity in IPOs, the market performance will improve, with higher demand for new stocks in popular sectors such as consumption, medical, and technology. Companies with cornerstone investors holding 30%-50% of shares are performing stronger, and the A-share market is also expected to benefit.

wallstreetcnJul 17, 2025 11:31

HK IPO Weekly Report | Biopharmaceutical company Hancest Therapeutics files for listing, Zhou Liu Fu and Zhejiang Sanhua Intelligent Controls pass listing hearings

① What are the key highlights of the IPO filing by biopharmaceutical company Hanesaitai? ② Zhejiang Sanhua Intelligent Controls has passed the listing hearing, how is the company's profitability?

cls.cnJun 8, 2025 16:20

Institutions: How will the stock price perform after being included in the Stock Connect? Which companies are likely to be included this year?

Can the increased allocation of southbound funds after 'inclusion' provide a timing opportunity based on 'funding conditions'?

Guangfa strategyJun 4, 2025 10:12

Dalu International Group Seeks Nasdaq Capital Market Listing Under Symbol DLHZ

Dow JonesFeb 26, 2025 05:06

Dalu International Group Expects to Offer 1.5M Shrs at Price Between $4 and $6 Each

Dow JonesFeb 26, 2025 05:03

Dalu International Group Files for IPO

Dow JonesFeb 26, 2025 05:02